Dr. Robert Reid of Virginia Cancer Specialists presents data on an important Study for Prostate Cancer

® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation

SALT LAKE CITY, Feb. 07, 2018 (GLOBE NEWSWIRE) —  Find out more here, read the full article.

Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that results from a large 1,162 patient study of the Myriad myRisk^® Hereditary Cancer test will be featured during the poster presentation at the 2018 Genitourinary Cancer Symposium in San Francisco, Calif.  The key finding is that more than 12 percent of men with prostate cancer had an inherited (i.e. hereditary) mutation in a cancer-causing gene.

Learn about Genetic Testing at Virginia Cancer Specialists Here